Abstract

ObjectivesThe aim of this study is to investigate if correlations exist between income inequality and antimicrobial resistance. This study’s hypothesis is that income inequality at the national level is positively correlated with antimicrobial resistance within developed countries.Data collection and analysisIncome inequality data were obtained from the Standardized World Income Inequality Database. Antimicrobial resistance data were obtained from the European antimicrobial Resistance Surveillance Network and outpatient antimicrobial consumption data, measured by Defined daily Doses per 1000 inhabitants per day, from the European Surveillance of antimicrobial Consumption group. Spearman’s correlation coefficient (r) defined strengths of correlations of: > 0.8 as strong, > 0.5 as moderate and > 0.2 as weak. Confidence intervals and p values were defined for all r values. Correlations were calculated for the time period 2003-10, for 15 European countries.ResultsIncome inequality and antimicrobial resistance correlations which were moderate or strong, with 95% confidence intervals > 0, included the following. Enterococcus faecalis resistance to aminopenicillins, vancomycin and high level gentamicin was moderately associated with income inequality (r= ≥0.54 for all three antimicrobials). Escherichia coli resistance to aminoglycosides, aminopenicillins, third generation cephalosporins and fluoroquinolones was moderately-strongly associated with income inequality (r= ≥0.7 for all four antimicrobials). Klebsiella pneumoniae resistance to third generation cephalosporins, aminoglycosides and fluoroquinolones was moderately associated with income inequality (r= ≥0.5 for all three antimicrobials). Staphylococcus aureus methicillin resistance and income inequality were strongly associated (r=0.87).ConclusionAs income inequality increases in European countries so do the rates of antimicrobial resistance for bacteria including E. faecalis, E. coli, K. pneumoniae and S. aureus. Further studies are needed to confirm these findings outside Europe and investigate the processes that could causally link income inequality and antimicrobial resistance.

Highlights

  • Antimicrobial therapy has contributed greatly to improvements in human health care through the treatment of infectious diseases

  • This study showed income inequality to be positively correlated with antimicrobial resistance in all seven species analysed: E. faecalis, E. faecium, E. coli, K. pneumoniae, P. aeruginosa, S. aureus and S. pneumoniae

  • Inequality was correlated with antimicrobial consumption, and antimicrobial consumption was correlated with antimicrobial resistance

Read more

Summary

Introduction

Antimicrobial therapy has contributed greatly to improvements in human health care through the treatment of infectious diseases. Wilkinson and Pickett have shown that higher rates of diabetes and mental illness (including drug and alcohol addiction) are associated with higher levels of income inequality at the national level [5], within developed countries (data from developing countries are unavailable to make similar comparisons). This raises the question of whether income inequality is associated with infection-related health care outcomes, such as antimicrobial resistance. This study investigated the associations between income inequality, antimicrobial resistance and antimicrobial consumption within developed countries, via calculation of correlation coefficients between these variables

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call